Guardian Capital Advisors LP Zoetis Inc. Transaction History

Guardian Capital Advisors LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$160.94 - $186.23 $482,820 - $558,690	-3,000 Reduced 29.51%	7,165 $1.23 Million
Q1 2023 May 15, 2023	SELL	$145.48 - $175.02 $609,561 - $733,333	-4,190 Reduced 29.19%	10,165 $1.69 Million
Q4 2022 Feb 14, 2023	BUY	$131.14 - $157.47 $1.88 Million - $2.26 Million	14,355 New	14,355 $2.1 Million

1,923

424M

1.15M

1.2M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $83.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Guardian Capital Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Guardian Capital Advisors LP with notifications on news.